Form 4: Teladoc Health's Chief Medical Officer Reports Stock Transactions
SEC Form 4 Filing
Vidya Raman-Tangella, Chief Medical Officer of Teladoc Health, reports the acquisition and disposal of company stock and restricted stock units.
Summary
- On August 1, 2024, Vidya Raman-Tangella, the Chief Medical Officer of Teladoc Health, exercised restricted stock units converting them into 10,244 shares of common stock.
- On August 2, 2024, Ms. Raman-Tangella sold 3,857 shares of common stock at a price of $8.142 per share.
- Following these transactions, Ms. Raman-Tangella directly owns 33,667 shares of Teladoc Health common stock and 30,732 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing, indicating neutral sentiment. It simply reports transactions without expressing any opinion on the company's performance or future prospects.
Industry Context
This is a routine disclosure of insider trading activity and doesn't necessarily reflect a broader trend in the telehealth industry.
Key Dates
| Date | Description |
|---|---|
| May 1, 2022 | Reporting person was granted 122,927 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 08/01/2024 | Restricted stock units converted to shares of TDOC common stock. |
| 08/02/2024 | Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. |
| 08/05/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.